Tolerability and efficacy of rituximab-containing immunochemotherapy in patients with B-cell non-Hodgkin lymphoma receiving hemodialysis

Yotaro OchiDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan;

Nobuhiro HiramotoDepartment of Cell Therapy, Institute of Biomedical Research and Innovation, Kobe, Japan; Correspondence[email protected]

Yuichiro OnoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan;

Satoshi YoshiokaDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan;

Sumie TabataDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan;

Noboru YonetaniDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan;

Akiko MatsushitaDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan;

Yukihiro ImaiDepartment of Clinical Pathology, Kobe City Medical Center General Hospital, Kobe, Japan

Takayuki IshikawaDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan;

Your download is now in progress and you may close this window